Goldstein David M
Chief Scientific Officer
Goldstein David M has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 5, 2026.
On the most recent filing, Goldstein David M is listed as Chief Scientific Officer at ALUMIS INC. Inside the rolling window, Goldstein David M reported no open-market purchases and 1 open-market sale totaling $68K in ALMS.
Companies traded
Other insiders at ALMS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$68K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Goldstein David M made?
Goldstein David M has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Goldstein David M trade?
Goldstein David M has filed SEC Form 4 disclosures for 1 company, including ALMS.
When was Goldstein David M's most recent SEC Form 4 filing?
Goldstein David M's most recent SEC Form 4 filing on Tracefour is dated Aug 5, 2026.
What is Goldstein David M's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Goldstein David M is listed as Chief Scientific Officer.
What is Goldstein David M's total buy and sell value in the current window?
Inside the rolling retention window, Goldstein David M bought $0 and sold $68K based on SEC Form 4 filings.
What was Goldstein David M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,596 ALMS shares on 2026-08-03, worth $68K, per SEC Form 4 filings.